Contemporary Clinical Trials Communications

Contemporary Clinical Trials Communications is an international, peer-reviewed open access journal dedicated to the field of clinical trials. This journal aims to provide a high-quality communication platform for the design, implementation, analysis, and reporting of clinical trials, in order to promote the development of the fields of medicine and biological sciences. The main goal of the magazine is to publish original research, review articles, case reports, newsletters, conference reports, and other types of articles, covering various stages of clinical trials, including trial design, data collection, statistical analysis, result interpretation, and policy formulation. In addition, the magazine also focuses on ethical issues, patient safety, data management, and regulatory policies in clinical trials. Through high-quality research articles and providing a professional communication platform, this journal is committed to promoting the development of the fields of medicine and biological sciences, providing support for the design, implementation, analysis, and reporting of clinical trials.

《当代临床试验通讯》是一本专注于临床试验领域的国际性、同行评审的开放获取期刊。该杂志旨在为临床试验的设计、实施、分析和报告提供一个高质量的交流平台，以促进医学和生物科学领域的发展。杂志的主要目标是发表原创研究、综述文章、案例报告、简讯、会议报告等类型的文章，涵盖临床试验的各个阶段，包括试验设计、数据收集、统计分析、结果解释和政策制定等。此外，该杂志还关注临床试验中的伦理问题、患者安全、数据管理和监管政策等方面的内容。通过高质量的研究文章和提供专业的交流平台，该杂志致力于推动医学和生物科学领域的发展，为临床试验的设计、实施、分析和报告提供支持。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映Pharmacology, Toxicology and Pharmaceutics-Pharmacology领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为1.4，平均审稿速度为 20 Weeks ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。